Subbarao Jayanthi

Focusing on prevention, diagnosis, treatment, and care monitoring during the patient journey in oncology to create value for stakeholders.

Examining the current biosimilar market.

A check on the evolving challenges and potential solutions in steering future market adoption of curative-intended treatments.

While gene therapies continue to revolutionize healthcare, uncertainty from commercialization issues still looms large.